Date: Thursday, March 24, 2016Year: 2016Location: Palais des Congrès de Paris, niveau 3Content-type: current_conferences (Source: The Aspergillus Website - updates)

This multicentre, double-blind, randomised, placebo-controlled, crossover study aimed to determine the dose-response of the long-acting muscarinic antagonist (LAMA) glycopyrronium bromide (GB) when added to beclometasone dipropionate plus formoterol fumarate (BDP/FF) in patients with COPD.Patients received extrafine GB 12.5, 25 or 50μg twice daily (BID) or placebo for 7 days via pressurised metered dose inhaler (pMDI), and extrafine BDP/FF via pMDI throughout the study. The primary objective was to demonstrate superiority of GB plus BDP/FF versus BDP/FF in terms of FEV1 area under the curve from 0–12 hours (AUC0-12h) on Day 7. (Source: Respiratory Medicine CME)

(NaturalNews) A serious new respiratory virus with a high mortality rate may have the potential to be transmitted by air, according to a study conducted by researchers from King Fahd Medical Research Center in Saudi Arabia and published in the journal mBio last summer.This would... (Source: NaturalNews.com)

ConclusionCurcumin protects against MTB infection in human macrophages. The host‐protective role of curcumin against MTB in macrophages needs confirmation in an animal model; if validated, the immunomodulatory anti‐TB effects of curcumin would be less prone to drug resistance development. (Source: Respirology)